With the emergence of SARS-CoV-2, healthcare systems not only had to address the pressing clinical needs of the COVID-19 pandemic but anticipate the effect on and of other conditions and diseases. This was of particular concern in areas of the world endemic with malaria, a disease which takes hundreds of thousands of lives each year. This case report from Thailand describes a 25-year-old man diagnosed with Plasmodium vivax, who was then found to be co-infected with COVID-19. Both conditions can have overlapping acute febrile illness symptoms which may delay or complicate diagnoses. He had no prior history of malaria and had received two vaccinations against COVID-19. His clinical course was mild with no pulmonary complications or oxygen requirement, and he responded well to treatments for both conditions. Three months after cure, he again contracted COVID-19 but did not experience any P. vivax relapse. Review of the available literature produced less than 10 publications describing co-infections with P. vivax and COVID-19; nonetheless, in endemic areas, vigilance for both diseases should continue, as co-infections could significantly alter the course of clinical management and prognosis as well as affect the healthcare staff caring for these patients.
While vector control methods have successfully reduced malaria rates worldwide, such methods are not always suitable for military use. We evaluated the usability, durability, and effectiveness of permethrin-treated uniforms and metofluthrin spatial repellent in preventing mosquito bites among soldiers in the Laos People’s Army that were deployed on a 12-week field exercise. The study enrolled 173 subjects into four different groups: (1) metofluthrin-only, (2) permethrin-treated uniforms, (3) metofluthrin with permethrin-treated uniforms, and (4) a control group. We measured efficacy through self-reported survey responses and a serological test for antibodies to Anopheles salivary antigens and assessed the durability of permethrin treatment over the 12-week exercise. We found that soldiers given metofluthrin and permethrin-treated uniforms were 72% and 46% more likely to report decreased mosquito bites compared to those in the control group and that soldiers with permethrin-treated uniforms had significantly lower (p < 0.05) antibody levels to the Anopheles SG6 salivary antigen. Mass spectrometry analysis revealed that treated uniforms still contained a significant permethrin concentration that showed 50 to 100% mosquito mortality. Overall, our findings show that both metofluthrin and permethrin-treated uniforms were well-tolerated and led to significantly fewer reported mosquito bites, and that permethrin, in particular, was found to be durable throughout the 12-week field exercise and effective in reducing mosquito bite exposure, underscoring its value in military applications.
The Indo-Pacific region hosts several annual military exercises that involve the deployment of thousands of U.S. and partner-nation military personnel. Respiratory and diarrheal diseases pose a significant health risk to exercise participants and represent a substantial portion of medical encounters and lost duty days. We conducted surveillance for respiratory and diarrheal illness at the Cobra Gold and Balikatan military exercises in Thailand and the Philippines from 2023–2025. Through coordination with health providers in the field, military personnel that reported acute symptoms were asked to provide a nasopharyngeal swab or stool sample. These samples were transported to a field lab and tested by PCR for common respiratory and diarrheal pathogens. Follow-up analyses included bacterial culture, antimicrobial susceptibility testing, and viral whole-genome sequencing. From 84 respiratory and 61 diarrheal samples analyzed, we found that respiratory illness was primarily attributed to rhinoviruses/enteroviruses (23%), common coronaviruses (21%), and SARS-CoV-2 (11%) while diarrheal disease was attributed to a high rate of diarrheagenic E. coli (73%) and norovirus (20%), followed by Salmonella spp. (18%) and Campylobacter spp. (13%). Our findings highlight the distinct etiologies of respiratory and diarrheal disease in military field settings and demonstrate the feasibility of conducting real-time infectious disease surveillance in operational environments.